These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10599071

  • 1. [Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].
    Ostwald E, Sabri O, Cremerius U, Jakse G, Büll U.
    Nuklearmedizin; 1999; 38(7):302-5. PubMed ID: 10599071
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Use of bone scintigraphy in the evaluation of bone involvement by prostatic cancer treated with a LHRH-antiandrogen combination].
    Lacourcière Y, Dupont A, Giguère M, Labrie F.
    Union Med Can; 1986 Apr; 115(4):229-34. PubMed ID: 3521035
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sub-super bone scan caused by bone marrow involvement of prostate cancer.
    Seo Y, Shuke N, Yamamoto W, Usui K, Aburano T.
    Ann Nucl Med; 1999 Oct; 13(5):351-4. PubMed ID: 10582806
    [Abstract] [Full Text] [Related]

  • 8. Bone tracer uptake in urinary bladder stones.
    Onur Demirkol M, Seymen H, Ihsan Kölgesiz A, Kadioğlu A.
    Clin Nucl Med; 2003 Apr; 28(4):337-9. PubMed ID: 12642723
    [No Abstract] [Full Text] [Related]

  • 9. Cold metastases detected by bone scintigraphy in aggressive lung cancer.
    Martínez Carsí C, Ruíz Hernández G, Sánchez Marchori C, Oro Camps J, Perales Vila A.
    Nuklearmedizin; 1998 Apr; 37(8):292-6. PubMed ID: 9868712
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation.
    Caglar M, Tuncel M.
    Clin Nucl Med; 2002 Jul; 27(7):532-3. PubMed ID: 12072787
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L.
    Anticancer Res; 1997 Jul; 17(3B):1615-8. PubMed ID: 9179204
    [Abstract] [Full Text] [Related]

  • 15. [Scintigraphic control of bone metastases of prostatic cancer treated with cytonal and cyclophosphamide].
    Grossmann J, Weiss M, Deckart H, Raatzsch H.
    Radiobiol Radiother (Berl); 1988 Jul; 29(6):736-8. PubMed ID: 3253797
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma.
    Kalin B, Jacobsson H.
    Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.